NOV Inc. Stock
Price
Target price
€12.32
€12.32
-6.490%
-0.855
-6.490%
€15.56
21.11.25 / Stuttgart Stock Exchange
WKN: A2QLRE / Symbol: NOV / Name: NOV / Stock / Oil & Gas Related Equipment and Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
NOV Inc. Stock
Heavy losses for NOV Inc. today as the stock fell by -€0.855 (-6.490%).
Currently there is a rather positive sentiment for NOV Inc. with 15 Buy predictions and 6 Sell predictions.
With a target price of 15 € there is a positive potential of 21.8% for NOV Inc. compared to the current price of 12.32 €.
Our community identified positive and negative aspects for NOV Inc. stock for the coming years. 1 users see the criterium "Balance Sheet Risk" as a plus for the NOV Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of NOV Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of NOV Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| NOV Inc. | -6.490% | -8.028% | 12.775% | -21.435% | -10.954% | -43.509% | 20.264% |
| Cimc Enric Holdings Inc. | - | 5.590% | -4.494% | 6.250% | 1.190% | -14.011% | 88.053% |
| John Wood Group | 0.980% | 10.945% | 28.038% | -55.878% | -64.789% | -84.795% | -91.065% |
| Core Laboratories Inc. | -6.250% | -8.397% | 17.647% | -40.594% | -25.000% | -39.394% | -31.034% |
Comments
NOV (NYSE:NOV) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Show more
Ratings data for NOV provided by MarketBeat
NOV (NYSE:NOV) was given a new $19.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
Show more
Ratings data for NOV provided by MarketBeat
NOV (NYSE:NOV) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $19.00 price target on the stock.
Show more
Ratings data for NOV provided by MarketBeat